Compositions methods and kits for enhancing immune response to a respiratory condition

Details for Australian Patent Application No. 2009212295 (hide)

Owner The Procter & Gamble Company

Inventors Lawson, David Alexander; Ebel, James Patrick; Gildea, Lucy Anne; Clymer, Jeffrey Warren

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009212295

PCT Pub. Number WO2009/100331

Priority 61/063,735 06.02.08 US

Filing date 6 February 2009

Wipo publication date 13 August 2009

International Classifications

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/100331 Priority application(s): WO2009/100331

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009212309-Rescue of photoreceptors by intravitreal administation of an expression vector encoding a therapeutic protein

2009212286-Accommodative IOL with dynamic spherical aberration